OVID Return on Tangible Equity | Ovid Therapeutics Inc.

Ovid Therapeutics Inc. (OVID) Return on Tangible Equity

2026-06-30: Return Tang Equity -16.43%.
2026-03-31: Return Tang Equity -12.19%.
2025-12-31: Return Tang Equity -13.33%.
2025-09-30: Return Tang Equity -81.28%.

Complete source-backed return tang equity history.

Available history: 2015-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-16.43%
2026-03-31	-12.19%
2025-12-31	-13.33%
2025-09-30	-81.28%
2025-06-30	-68.43%
2025-03-31	-42.16%
2024-12-31	-38.80%
2024-09-30	-42.69%
2024-06-30	-33.54%
2024-03-31	-64.86%
2023-12-31	-59.75%
2023-09-30	-48.01%
2023-06-30	-44.58%
2023-03-31	-42.58%
2022-12-31	-41.02%
2022-09-30	-48.43%
2022-06-30	-44.84%
2022-03-31	-42.05%
2021-12-31	68.40%
2021-09-30	64.43%
2021-06-30	58.97%
2021-03-31	52.07%
2020-12-31	-187.09%
2020-09-30	-120.06%
2020-06-30	-253.05%
2020-03-31	-130.74%
2019-12-31	-86.92%
2019-09-30	-189.90%
2019-06-30	-116.72%
2019-03-31	-92.41%
2018-12-31	-135.32%
2018-09-30	-100.96%
2018-06-30	-76.37%
2018-03-31	-60.82%
2017-12-31	-77.79%
2017-09-30	-66.14%
2017-06-30	-57.37%
2017-03-31	-125.49%
2016-12-31	-45.57%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-13.33%
2024-12-31	-38.80%
2023-12-31	-59.75%
2022-12-31	-41.02%
2021-12-31	68.40%
2020-12-31	-187.09%
2019-12-31	-86.92%
2018-12-31	-135.32%
2017-12-31	-77.79%
2016-12-31	-45.57%
2015-12-31	-19.33%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ASSEMBLY BIOSCIENCES, INC. (ASMB)	United States	$0.481B	-13,053.96
CAPRICOR THERAPEUTICS, INC. (CAPR)	United States	$0.499B	-10.81
PUMA BIOTECHNOLOGY, INC. (PBYI)	United States	$0.507B	15.53
ARVINAS, INC. (ARVN)	United States	$0.510B	58.38
MapLight Therapeutics, Inc. (MPLT)	United States	$0.459B	-7.10
Evolus, Inc. (EOLS)	United States	$0.519B	-13.32
CRESCENT BIOPHARMA, INC. (CBIO)	United States	$0.529B	-5.20
Quoin Pharmaceuticals Ltd. (QNRX)		$0.443B	-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63
Indaptus Therapeutics, Inc. (INDP)	United States	$0.537B